<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37533870</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1202850</StartPage><MedlinePgn>1202850</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1202850</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1202850</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly affects women of childbearing age and is characterized by the damage to multiple target organs. The pathogenesis of SLE is complex, and its etiology mainly involves genetic and environmental factors. At present, there is still a lack of effective means to cure SLE. In recent years, growing evidence has shown that gut microbiota, as an environmental factor, triggers autoimmunity through potential mechanisms including translocation and molecular mimicry, leads to immune dysregulation, and contributes to the development of SLE. Dietary intervention, drug therapy, probiotics supplement, fecal microbiome transplantation and other ways to modulate gut microbiota appear to be a potential treatment for SLE. In this review, the dysbiosis of gut microbiota in SLE, potential mechanisms linking gut microbiota and SLE, and immune dysregulation associated with gut microbiota in SLE are summarized.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Yao, Xie, Wang, Lin, Chen and Zhou.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Kaijin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yina</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiali</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yongda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiutian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Tianbiao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Nephrology, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069467" MajorTopicYN="N">Fecal Microbiota Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">dysbiosis</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">immune dysregulation</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>4</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37533870</ArticleId><ArticleId IdType="pmc">PMC10390700</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1202850</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. . Systemic lupus erythematosus. Nat Rev Dis Primers (2016) 2:16039. doi: 10.1038/nrdp.2016.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis (2023) 82:351&#x2013;6. doi: 10.1136/ard-2022-223035</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard-2022-223035</ArticleId><ArticleId IdType="pmc">PMC9933169</ArticleId><ArticleId IdType="pubmed">36241363</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med (2017) 23:615&#x2013;35. doi: 10.1016/j.molmed.2017.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2017.05.006</ArticleId><ArticleId IdType="pmc">PMC5650102</ArticleId><ArticleId IdType="pubmed">28623084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr (2020) 16:19&#x2013;30. doi: 10.1007/s12519-019-00229-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap DYH, Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci (2019) 20:6231. doi: 10.3390/ijms20246231</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun (2022) 132:102870. doi: 10.1016/j.jaut.2022.102870</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102870</ArticleId><ArticleId IdType="pubmed">35872102</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE, et al. . Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol (2008) 181:8761&#x2013;6. doi: 10.4049/jimmunol.181.12.8761</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.12.8761</ArticleId><ArticleId IdType="pmc">PMC2596652</ArticleId><ArticleId IdType="pubmed">19050297</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JJ, Jacob A, Chang A, Quigg RJ, Jarvis JN. Double negative T cells, a potential biomarker for systemic lupus erythematosus. Precis Clin Med (2020) 3:34&#x2013;43. doi: 10.1093/pcmedi/pbaa001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pcmedi/pbaa001</ArticleId><ArticleId IdType="pmc">PMC7093895</ArticleId><ArticleId IdType="pubmed">32257532</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhang X, Cao X. Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications. J Autoimmun (2022) 132:102856. doi: 10.1016/j.jaut.2022.102856</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102856</ArticleId><ArticleId IdType="pubmed">35773101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol (2017) 185:59&#x2013;73. doi: 10.1016/j.clim.2016.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.08.010</ArticleId><ArticleId IdType="pmc">PMC5299061</ArticleId><ArticleId IdType="pubmed">27519955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Tong Y, Liu Y, Hu H. Self-dsDNA in the pathogenesis of systemic lupus erythematosus. Clin Exp Immunol (2018) 191:1&#x2013;10. doi: 10.1111/cei.13041</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13041</ArticleId><ArticleId IdType="pmc">PMC5721232</ArticleId><ArticleId IdType="pubmed">28836661</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekvig OP, van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol (2014) 36:301&#x2013;11. doi: 10.1007/s00281-014-0428-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-014-0428-6</ArticleId><ArticleId IdType="pubmed">24763531</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolouri N, Akhtari M, Farhadi E, Mansouri R, Faezi ST, Jamshidi A, et al. . Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus. Inflammation Res (2022) 71:537&#x2013;54. doi: 10.1007/s00011-022-01554-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01554-6</ArticleId><ArticleId IdType="pubmed">35298669</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JMP, Parks CG, Jacobsen S, Costenbader KH, Bernatsky S. The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. J Intern Med (2022) 291:755&#x2013;78. doi: 10.1111/joim.13448</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13448</ArticleId><ArticleId IdType="pubmed">35143075</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M, Alarc&#xf3;n-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun (2016) 74:161&#x2013;75. doi: 10.1016/j.jaut.2016.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.08.001</ArticleId><ArticleId IdType="pubmed">27522116</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 18:871&#x2013;82. doi: 10.1038/nm.2752</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2752</ArticleId><ArticleId IdType="pmc">PMC3607103</ArticleId><ArticleId IdType="pubmed">22674006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf SJ, Estadt SN, Gudjonsson JE, Kahlenberg JM. Human and murine evidence for mechanisms driving autoimmune photosensitivity. Front Immunol (2018) 9:2430. doi: 10.3389/fimmu.2018.02430</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02430</ArticleId><ArticleId IdType="pmc">PMC6205973</ArticleId><ArticleId IdType="pubmed">30405625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Quintial R, Mayeux JM, Kono DH, Theofilopoulos AN, Pollard KM, Baccala R. Silica exposure and chronic virus infection synergistically promote lupus-like systemic autoimmunity in mice with low genetic predisposition. Clin Immunol (2019) 205:75&#x2013;82. doi: 10.1016/j.clim.2019.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2019.06.003</ArticleId><ArticleId IdType="pmc">PMC6646094</ArticleId><ArticleId IdType="pubmed">31175964</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer CB, Costenbader KH. Cigarette smoking and the pathogenesis of systemic lupus erythematosus. Expert Rev Clin Immunol (2018) 14:481&#x2013;7. doi: 10.1080/1744666X.2018.1473035</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1473035</ArticleId><ArticleId IdType="pmc">PMC7069669</ArticleId><ArticleId IdType="pubmed">29724134</ArticleId></ArticleIdList></Reference><Reference><Citation>Illescas-Montes R, Corona-Castro CC, Melguizo-Rodr&#xed;guez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology (2019) 158:153&#x2013;60. doi: 10.1111/imm.13103</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13103</ArticleId><ArticleId IdType="pmc">PMC6797874</ArticleId><ArticleId IdType="pubmed">31386190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JW, Kim HA, Suh CH, Jung JY. Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Front Med (Lausanne) (2022) 9:906475. doi: 10.3389/fmed.2022.906475</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.906475</ArticleId><ArticleId IdType="pmc">PMC9402996</ArticleId><ArticleId IdType="pubmed">36035435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun (2019) 96:1&#x2013;13. doi: 10.1016/j.jaut.2018.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.11.001</ArticleId><ArticleId IdType="pmc">PMC6310637</ArticleId><ArticleId IdType="pubmed">30448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med (2020) 172:Itc81&#x2013;itc96. doi: 10.7326/AITC202006020</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaheen WA, Quraishi MN, Iqbal TH. Gut microbiome and autoimmune disorders. Clin Exp Immunol (2022) 209:161&#x2013;74. doi: 10.1093/cei/uxac057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cei/uxac057</ArticleId><ArticleId IdType="pmc">PMC9390838</ArticleId><ArticleId IdType="pubmed">35652460</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 4:1095&#x2013;119. doi: 10.3390/nu4081095</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu4081095</ArticleId><ArticleId IdType="pmc">PMC3448089</ArticleId><ArticleId IdType="pubmed">23016134</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanisavljevi&#x107; S, Luki&#x107; J, Mom&#x10d;ilovi&#x107; M, Miljkovi&#x107; M, Jevti&#x107; B, Koji&#x107; M, et al. . Gut-associated lymphoid tissue, gut microbes and susceptibility to experimental autoimmune encephalomyelitis. Benef Microbes (2016) 7:363&#x2013;73. doi: 10.3920/BM2015.0159</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2015.0159</ArticleId><ArticleId IdType="pubmed">26839070</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen BD, Jia XM, Xu JY, Zhao LD, Ji JY, Wu BX, et al. . An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arthritis Rheumatol (2021) 73:232&#x2013;43. doi: 10.1002/art.41511</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41511</ArticleId><ArticleId IdType="pubmed">33124780</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Yi P, Zhu M, Zhou W, Zhang B, Yi X, et al. . Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: an EXPLORER trial. J Autoimmun (2022) 130:102844. doi: 10.1016/j.jaut.2022.102844</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2022.102844</ArticleId><ArticleId IdType="pubmed">35690527</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liao X, Sparks JB, Luo XM. Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol (2014) 80:7551&#x2013;60. doi: 10.1128/AEM.02676-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02676-14</ArticleId><ArticleId IdType="pmc">PMC4249226</ArticleId><ArticleId IdType="pubmed">25261516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Zhang H, Liao X, Lin K, Liu H, Edwards MR, et al. . Control of lupus nephritis by changes of gut microbiota. Microbiome (2017) 5:73. doi: 10.1186/s40168-017-0300-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0300-8</ArticleId><ArticleId IdType="pmc">PMC5505136</ArticleId><ArticleId IdType="pubmed">28697806</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo XM, Edwards MR, Mu Q, Yu Y, Vieson MD, Reilly CM, et al. . Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol (2018) 84:e02288-17. doi: 10.1128/AEM.02288-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02288-17</ArticleId><ArticleId IdType="pmc">PMC5795066</ArticleId><ArticleId IdType="pubmed">29196292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegarra-Ruiz DF, El Beidaq A, I&#xf1;iguez AJ, Lubrano Di Ricco M, Manfredo Vieira S, Ruff WE, et al. . A diet-sensitive commensal lactobacillus strain mediates TLR7-dependent systemic autoimmunity. Cell Host Microbe (2019) 25:113&#x2013;27.e6. doi: 10.1016/j.chom.2018.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.11.009</ArticleId><ArticleId IdType="pmc">PMC6377154</ArticleId><ArticleId IdType="pubmed">30581114</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhamid L, Cabana-Puig X, Swartwout B, Lee J, Li S, Sun S, et al. . Retinoic acid exerts disease stage-dependent effects on pristane-induced lupus. Front Immunol (2020) 11:408. doi: 10.3389/fimmu.2020.00408</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00408</ArticleId><ArticleId IdType="pmc">PMC7103630</ArticleId><ArticleId IdType="pubmed">32265909</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Xu H, Xu J, Zhao H, Lin Q, Zhou Y, et al. . Sodium butyrate ameliorates gut microbiota dysbiosis in lupus-like mice. Front Nutr (2020) 7:604283. doi: 10.3389/fnut.2020.604283</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2020.604283</ArticleId><ArticleId IdType="pmc">PMC7688247</ArticleId><ArticleId IdType="pubmed">33262998</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Toral M, G&#xf3;mez-Guzm&#xe1;n M, S&#xe1;nchez M, Mole&#xf3;n J, et al. . Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus. Br J Pharmacol (2021) 178:3708&#x2013;29. doi: 10.1111/bph.15512</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15512</ArticleId><ArticleId IdType="pubmed">33931880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DS, Park Y, Choi JW, Park SH, Cho ML, Kwok SK. Lactobacillus acidophilus supplementation exerts a synergistic effect on tacrolimus efficacy by modulating Th17/Treg balance in lupus-prone mice via the SIGNR3 pathway. Front Immunol (2021) 12:696074. doi: 10.3389/fimmu.2021.696074</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.696074</ArticleId><ArticleId IdType="pmc">PMC8704231</ArticleId><ArticleId IdType="pubmed">34956169</ArticleId></ArticleIdList></Reference><Reference><Citation>Toumi E, Goutorbe B, Plauzolles A, Bonnet M, Mezouar S, Militello M, et al. . Gut microbiota in systemic lupus erythematosus patients and lupus mouse model: a cross species comparative analysis for biomarker discovery. Front Immunol (2022) 13:943241. doi: 10.3389/fimmu.2022.943241</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.943241</ArticleId><ArticleId IdType="pmc">PMC9378784</ArticleId><ArticleId IdType="pubmed">35983031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang G, Banerjee N, Liang Y, Du X, Boor PJ, et al. . Aberrant gut microbiome contributes to intestinal oxidative stress, barrier dysfunction, inflammation and systemic autoimmune responses in MRL/lpr mice. Front Immunol (2021) 12:651191. doi: 10.3389/fimmu.2021.651191</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.651191</ArticleId><ArticleId IdType="pmc">PMC8071869</ArticleId><ArticleId IdType="pubmed">33912174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YF, Hsieh AH, Wang LC, Huang YJ, Yun-Chen T, Tseng WY, et al. . Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease. Sci Rep (2021) 11:22953. doi: 10.1038/s41598-021-02422-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02422-9</ArticleId><ArticleId IdType="pmc">PMC8616951</ArticleId><ArticleId IdType="pubmed">34824318</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiente GR, Munir A, Hart ML, Blough P, Wada TT, Dalan EE, et al. . Gut dysbiosis is associated with acceleration of lupus nephritis. Sci Rep (2022) 12:152. doi: 10.1038/s41598-021-03886-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03886-5</ArticleId><ArticleId IdType="pmc">PMC8742035</ArticleId><ArticleId IdType="pubmed">34996983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus. Mol Med (2019) 25:35. doi: 10.1186/s10020-019-0102-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-019-0102-5</ArticleId><ArticleId IdType="pmc">PMC6676588</ArticleId><ArticleId IdType="pubmed">31370803</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SC, Brown J, Gong M, Ge Y, Zadeh M, Li W, et al. . Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci Transl Med (2020) 12:eaax2220. doi: 10.1126/scitranslmed.aax2220</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax2220</ArticleId><ArticleId IdType="pmc">PMC7739186</ArticleId><ArticleId IdType="pubmed">32641487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Guo R, Sun Y, Li X, He L, Li Z, et al. . Lupus gut microbiota transplants cause autoimmunity and inflammation. Clin Immunol (2021) 233:108892. doi: 10.1016/j.clim.2021.108892</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108892</ArticleId><ArticleId IdType="pubmed">34813937</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, et al. . Alterations of the human gut microbiome in multiple sclerosis. Nat Commun (2016) 7:12015. doi: 10.1038/ncomms12015</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12015</ArticleId><ArticleId IdType="pmc">PMC4931233</ArticleId><ArticleId IdType="pubmed">27352007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. . The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med (2015) 21:895&#x2013;905. doi: 10.1038/nm.3914</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3914</ArticleId><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, et al. . The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature (2018) 562:589&#x2013;94. doi: 10.1038/s41586-018-0620-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0620-2</ArticleId><ArticleId IdType="pmc">PMC6296767</ArticleId><ArticleId IdType="pubmed">30356183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hevia A, Milani C, L&#xf3;pez P, Cuervo A, Arboleya S, Duranti S, et al. . Intestinal dysbiosis associated with systemic lupus erythematosus. mBio (2014) 5:e01548&#x2013;14. doi: 10.1128/mBio.01548-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01548-14</ArticleId><ArticleId IdType="pmc">PMC4196225</ArticleId><ArticleId IdType="pubmed">25271284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Shu Q, Song L, Liu Q, Qu X, Li M. Gut microbiota in systemic lupus erythematosus and correlation with diet and clinical manifestations. Front Med (Lausanne) (2022) 9:915179. doi: 10.3389/fmed.2022.915179</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.915179</ArticleId><ArticleId IdType="pmc">PMC9279557</ArticleId><ArticleId IdType="pubmed">35847775</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. . A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 464:59&#x2013;65. doi: 10.1038/nature08821</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08821</ArticleId><ArticleId IdType="pmc">PMC3779803</ArticleId><ArticleId IdType="pubmed">20203603</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog (2016) 8:64. doi: 10.1186/s13099-016-0146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-016-0146-9</ArticleId><ArticleId IdType="pmc">PMC5146896</ArticleId><ArticleId IdType="pubmed">27980687</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, et al. . Shared gut, but distinct oral microbiota composition in primary sj&#xf6;gren's syndrome and systemic lupus erythematosus. J Autoimmun (2019) 97:77&#x2013;87. doi: 10.1016/j.jaut.2018.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerges MA, Esmaeel NE, Makram WK, Sharaf DM, Gebriel MG. Altered profile of fecal microbiota in newly diagnosed systemic lupus erythematosus Egyptian patients. Int J Microbiol (2021) 2021:9934533. doi: 10.1155/2021/9934533</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9934533</ArticleId><ArticleId IdType="pmc">PMC8249152</ArticleId><ArticleId IdType="pubmed">34257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz-Agranov N, Zandman-Goddard G. The microbiome and systemic lupus erythematosus. Immunol Res (2017) 65:432&#x2013;7. doi: 10.1007/s12026-017-8906-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-017-8906-2</ArticleId><ArticleId IdType="pubmed">28233089</ArticleId></ArticleIdList></Reference><Reference><Citation>Widhani A, Djauzi S, Suyatna FD, Dewi BE. Changes in gut microbiota and systemic inflammation after synbiotic supplementation in patients with systemic lupus erythematosus: a randomized, double-blind, placebo-controlled trial. Cells (2022) 11:3419. doi: 10.3390/cells11213419</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11213419</ArticleId><ArticleId IdType="pmc">PMC9658918</ArticleId><ArticleId IdType="pubmed">36359816</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. . Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PloS One (2010) 5:e9085. doi: 10.1371/journal.pone.0009085</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009085</ArticleId><ArticleId IdType="pmc">PMC2816710</ArticleId><ArticleId IdType="pubmed">20140211</ArticleId></ArticleIdList></Reference><Reference><Citation>Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in crohn's disease. Nat Rev Gastroenterol Hepatol (2011) 8:152&#x2013;68. doi: 10.1038/nrgastro.2011.3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2011.3</ArticleId><ArticleId IdType="pubmed">21304476</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis (2021) 7:27. doi: 10.1038/s41531-021-00156-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00156-z</ArticleId><ArticleId IdType="pmc">PMC7946946</ArticleId><ArticleId IdType="pubmed">33692356</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz D, Omarbekova A, Heguy A, Schwudke D, Gisch N, Rovin BH, et al. . Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis (2019) 78:947&#x2013;56. doi: 10.1136/annrheumdis-2018-214856</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214856</ArticleId><ArticleId IdType="pmc">PMC6585303</ArticleId><ArticleId IdType="pubmed">30782585</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang HF, Li X, Li HX, Zhang Q, Zhou HW, et al. . Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci (Lond) (2019) 133:821&#x2013;38. doi: 10.1042/CS20180841</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180841</ArticleId><ArticleId IdType="pubmed">30872359</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Ren T, Li X, Zhai Q, Xu X, Zhang N, et al. . Distinct microbiomes of gut and saliva in patients with systemic lupus erythematous and clinical associations. Front Immunol (2021) 12:626217. doi: 10.3389/fimmu.2021.626217</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.626217</ArticleId><ArticleId IdType="pmc">PMC8281017</ArticleId><ArticleId IdType="pubmed">34276643</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Yang H, Wang Y, Xing Q, Yan L, Chai Y. Gut microbiome and fecal metabolic alteration in systemic lupus erythematosus patients with depression. Front Cell Infect Microbiol (2022) 12:1040211. doi: 10.3389/fcimb.2022.1040211</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1040211</ArticleId><ArticleId IdType="pmc">PMC9732533</ArticleId><ArticleId IdType="pubmed">36506019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu V, Quan M. SLE and serum complement: causative, concomitant or coincidental? Open Rheumatol J (2017) 11:113&#x2013;22. doi: 10.2174/1874312901711010113</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874312901711010113</ArticleId><ArticleId IdType="pmc">PMC5737025</ArticleId><ArticleId IdType="pubmed">29290848</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Fang H, Magder L, Petri M. Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity. Lupus (2013) 22:827&#x2013;34. doi: 10.1177/0961203313492578</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313492578</ArticleId><ArticleId IdType="pmc">PMC3703841</ArticleId><ArticleId IdType="pubmed">23761098</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Diaz J, Isenberg D, Ramsey-Goldman R. Measures of adult systemic lupus erythematosus: updated version of British isles lupus assessment group (BILAG 2004), European consensus lupus activity measurements (ECLAM), systemic lupus activity measure, revised (SLAM-r), systemic lupus activity questionnaire for population studies (SLAQ), systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K), and systemic lupus international collaborating Clinics/American college of rheumatology damage index (SDI). Arthritis Care Res (Hoboken) (2011) 63 Suppl 11:S37&#x2013;46. doi: 10.1002/acr.20572</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20572</ArticleId><ArticleId IdType="pmc">PMC3812450</ArticleId><ArticleId IdType="pubmed">22588757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagavant H, Araszkiewicz AM, Ingram JK, Cizio K, Merrill JT, Arriens C, et al. . Immune response to enterococcus gallinarum in lupus patients is associated with a subset of lupus-associated autoantibodies. Front Immunol (2021) 12:635072. doi: 10.3389/fimmu.2021.635072</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635072</ArticleId><ArticleId IdType="pmc">PMC8193979</ArticleId><ArticleId IdType="pubmed">34122404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SX, Wang J, Chen JW, Zhang MX, Zhang YF, Hu FY, et al. . The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus. Ann Rheum Dis (2021) 80:e177. doi: 10.1136/annrheumdis-2019-216504</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216504</ArticleId><ArticleId IdType="pubmed">31732515</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, et al. . Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes (2020) 11:1758&#x2013;73. doi: 10.1080/19490976.2020.1768644</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1768644</ArticleId><ArticleId IdType="pmc">PMC7524333</ArticleId><ArticleId IdType="pubmed">32507008</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang S, Qu Y, Qian S, Wang R, Wang Y, Jin Y, et al. . Association between systemic lupus erythematosus and disruption of gut microbiota: a meta-analysis. Lupus Sci Med (2022) 9:e000599. doi: 10.1136/lupus-2021-000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000599</ArticleId><ArticleId IdType="pmc">PMC8961174</ArticleId><ArticleId IdType="pubmed">35346981</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang K, Wang P, Xu Z, Hu YQ, He YS, Chen Y, et al. . Causal effects of gut microbiome on systemic lupus erythematosus: a two-sample mendelian randomization study. Front Immunol (2021) 12:667097. doi: 10.3389/fimmu.2021.667097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.667097</ArticleId><ArticleId IdType="pmc">PMC8453215</ArticleId><ArticleId IdType="pubmed">34557183</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoensappakit A, Sae-Khow K, Leelahavanichkul A. Gut barrier damage and gut translocation of pathogen molecules in lupus, an impact of innate immunity (Macrophages and neutrophils) in autoimmune disease. Int J Mol Sci (2022) 23:8223. doi: 10.3390/ijms23158223</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158223</ArticleId><ArticleId IdType="pmc">PMC9367802</ArticleId><ArticleId IdType="pubmed">35897790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorini C, Cosorich I, Lo Conte M, De Giorgi L, Facciotti F, Lucian&#xf2; R, et al. . Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci U.S.A. (2019) 116:15140&#x2013;9. doi:&#xa0;10.1073/pnas.1814558116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814558116</ArticleId><ArticleId IdType="pmc">PMC6660755</ArticleId><ArticleId IdType="pubmed">31182588</ArticleId></ArticleIdList></Reference><Reference><Citation>Secher T, Kassem S, Benamar M, Bernard I, Boury M, Barreau F, et al. . Oral administration of the probiotic strain escherichia coli nissle 1917 reduces susceptibility to neuroinflammation and repairs experimental autoimmune encephalomyelitis-induced intestinal barrier dysfunction. Front Immunol (2017) 8:1096. doi: 10.3389/fimmu.2017.01096</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01096</ArticleId><ArticleId IdType="pmc">PMC5603654</ArticleId><ArticleId IdType="pubmed">28959254</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. . Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science (2018) 359:1156&#x2013;61. doi: 10.1126/science.aar7201</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7201</ArticleId><ArticleId IdType="pmc">PMC5959731</ArticleId><ArticleId IdType="pubmed">29590047</ArticleId></ArticleIdList></Reference><Reference><Citation>Toral M, Robles-Vera I, Romero M, de la Visitaci&#xf3;n N, S&#xe1;nchez M, O'Valle F, et al. . Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB J (2019) 33:10005&#x2013;18. doi: 10.1096/fj.201900545RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900545RR</ArticleId><ArticleId IdType="pubmed">31173526</ArticleId></ArticleIdList></Reference><Reference><Citation>Thim-Uam A, Surawut S, Issara-Amphorn J, Jaroonwitchawan T, Hiengrach P, Chatthanathon P, et al. . Leaky-gut enhanced lupus progression in the fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus. Sci Rep (2020) 10:777. doi: 10.1038/s41598-019-57275-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57275-0</ArticleId><ArticleId IdType="pmc">PMC6972921</ArticleId><ArticleId IdType="pubmed">31964918</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman GJ, Deng J, Azzouz DF. Sex-dependent lupus blautia (Ruminococcus) gnavus strain induction of zonulin-mediated intestinal permeability and autoimmunity. Front Immunol (2022) 13:897971. doi: 10.3389/fimmu.2022.897971</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.897971</ArticleId><ArticleId IdType="pmc">PMC9405438</ArticleId><ArticleId IdType="pubmed">36032126</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Tavella VJ, Kirby JL, Cecere TE, Chung M, Lee J, et al. . Antibiotics ameliorate lupus-like symptoms in mice. Sci Rep (2017) 7:13675. doi: 10.1038/s41598-017-14223-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14223-0</ArticleId><ArticleId IdType="pmc">PMC5651817</ArticleId><ArticleId IdType="pubmed">29057975</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsayed NS, Aston P, Bayanagari VR, Shukla SK. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle. Front Immunol (2022) 13:972160. doi: 10.3389/fimmu.2022.972160</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.972160</ArticleId><ArticleId IdType="pmc">PMC9420973</ArticleId><ArticleId IdType="pubmed">36045671</ArticleId></ArticleIdList></Reference><Reference><Citation>Garabatos N, Santamaria P. Gut microbial antigenic mimicry in autoimmunity. Front Immunol (2022) 13:873607. doi: 10.3389/fimmu.2022.873607</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.873607</ArticleId><ArticleId IdType="pmc">PMC9094498</ArticleId><ArticleId IdType="pubmed">35572569</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling TM, Dehner C, Chen X, Hughes K, I&#xf1;iguez AJ, Boccitto M, et al. . Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med (2018) 10:eaan2306. doi: 10.1126/scitranslmed.aan2306</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aan2306</ArticleId><ArticleId IdType="pmc">PMC5918293</ArticleId><ArticleId IdType="pubmed">29593104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruff WE, Dehner C, Kim WJ, Pagovich O, Aguiar CL, Yu AT, et al. . Pathogenic autoreactive T and b cells cross-react with mimotopes expressed by a common human gut commensal to trigger autoimmunity. Cell Host Microbe (2019) 26:100&#x2013;13.e8. doi: 10.1016/j.chom.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC8194364</ArticleId><ArticleId IdType="pubmed">31227334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Chen X, Wan Q. Altered frequency of Th17 and treg cells in new-onset systemic lupus erythematosus patients. Eur J Clin Invest (2018) 48:e13012. doi: 10.1111/eci.13012</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13012</ArticleId><ArticleId IdType="pubmed">30079446</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Rodr&#xed;guez L, Mart&#xed;nez-Taboada V, Calvo-Al&#xe9;n J, Beares I, Villa I, L&#xf3;pez-Hoyos M. Altered Th17/Treg ratio in peripheral blood of systemic lupus erythematosus but not primary antiphospholipid syndrome. Front Immunol (2019) 10:391. doi: 10.3389/fimmu.2019.00391</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00391</ArticleId><ArticleId IdType="pmc">PMC6414457</ArticleId><ArticleId IdType="pubmed">30894863</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JY, Ho JH, Pasoto SG, Bunin V, Kim ST, Carrasco S, et al. . Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (2015) 67:988&#x2013;99. doi: 10.1002/art.39020</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39020</ArticleId><ArticleId IdType="pmc">PMC4450082</ArticleId><ArticleId IdType="pubmed">25581113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki-Imamura T, Yoshida Y, Suwabe K, Yoshimura F, Kato H. Molecular basis of indole production catalyzed by tryptophanase in the genus prevotella. FEMS Microbiol Lett (2011) 322:51&#x2013;9. doi: 10.1111/j.1574-6968.2011.02329.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.2011.02329.x</ArticleId><ArticleId IdType="pubmed">21658104</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez P, de Paz B, Rodr&#xed;guez-Carrio J, Hevia A, S&#xe1;nchez B, Margolles A, et al. . Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep (2016) 6:24072. doi: 10.1038/srep24072</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24072</ArticleId><ArticleId IdType="pmc">PMC4820712</ArticleId><ArticleId IdType="pubmed">27044888</ArticleId></ArticleIdList></Reference><Reference><Citation>Manirarora JN, Kosiewicz MM, Alard P. Feeding lactobacilli impacts lupus progression in (NZBxNZW)F1 lupus-prone mice by enhancing immunoregulation. Autoimmunity (2020) 53:323&#x2013;32. doi: 10.1080/08916934.2020.1777282</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2020.1777282</ArticleId><ArticleId IdType="pubmed">32552071</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Pan Y, Xia X, Liang J, Liu F, Dou H, et al. . Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in b cells. Eur J Pharmacol (2020) 884:173421. doi: 10.1016/j.ejphar.2020.173421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173421</ArticleId><ArticleId IdType="pubmed">32721450</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Visitaci&#xf3;n N, Robles-Vera I, Mole&#xf3;n-Moya J, S&#xe1;nchez M, Jim&#xe9;nez R, G&#xf3;mez-Guzm&#xe1;n M, et al. . Probiotics prevent hypertension in a murine model of systemic lupus erythematosus induced by toll-like receptor 7 activation. Nutrients (2021) 13:2669. doi:&#xa0;10.3390/nu13082669</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082669</ArticleId><ArticleId IdType="pmc">PMC8399640</ArticleId><ArticleId IdType="pubmed">34444829</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser EC, Mauri C. Regulatory b cells: origin, phenotype, and function. Immunity (2015) 42:607&#x2013;12. doi: 10.1016/j.immuni.2015.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.04.005</ArticleId><ArticleId IdType="pubmed">25902480</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Q, Edwards MR, Swartwout BK, Cabana Puig X, Mao J, Zhu J, et al. . Gut microbiota and bacterial DNA suppress autoimmunity by stimulating regulatory b cells in a murine model of lupus. Front Immunol (2020) 11:593353. doi: 10.3389/fimmu.2020.593353</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.593353</ArticleId><ArticleId IdType="pmc">PMC7683516</ArticleId><ArticleId IdType="pubmed">33240280</ArticleId></ArticleIdList></Reference><Reference><Citation>Moudgil KD. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases. Cytokine (2015) 74:1&#x2013;4. doi: 10.1016/j.cyto.2015.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.05.006</ArticleId><ArticleId IdType="pubmed">26026376</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuyama T, Tsokos GC, Moulton VR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol (2018) 9:1088. doi: 10.3389/fimmu.2018.01088</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01088</ArticleId><ArticleId IdType="pmc">PMC5967272</ArticleId><ArticleId IdType="pubmed">29868033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishimoto T, Hirano T. Molecular regulation of b lymphocyte response. Annu Rev Immunol (1988) 6:485&#x2013;512. doi: 10.1146/annurev.iy.06.040188.002413</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.06.040188.002413</ArticleId><ArticleId IdType="pubmed">3289574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol (2010) 40:1830&#x2013;5. doi: 10.1002/eji.201040391</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201040391</ArticleId><ArticleId IdType="pubmed">20583029</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yan C, Yu L, Zhang X, Shang J, Fan J, et al. . The star target in SLE: IL-17. Inflammation Res (2023) 72:313&#x2013;28. doi: 10.1007/s00011-022-01674-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01674-z</ArticleId><ArticleId IdType="pubmed">36538077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R, Xu R, Ding L, Sui W, Niu M, Wang M, et al. . Circulating IL-17 level is positively associated with disease activity in patients with systemic lupus erythematosus: a systematic review and meta-analysis. BioMed Res Int (2021) 2021:9952463. doi: 10.1155/2021/9952463</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9952463</ArticleId><ArticleId IdType="pmc">PMC8318742</ArticleId><ArticleId IdType="pubmed">34337065</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, et al. . IL-10 regulates murine lupus. J Immunol (2002) 169:2148&#x2013;55. doi: 10.4049/jimmunol.169.4.2148</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.169.4.2148</ArticleId><ArticleId IdType="pubmed">12165544</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol (2019) 14:369&#x2013;93. doi: 10.1146/annurev-pathol-020117-043952</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-020117-043952</ArticleId><ArticleId IdType="pubmed">30332560</ArticleId></ArticleIdList></Reference><Reference><Citation>Postal M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, Appenzeller S, Niewold TB. Type I interferon in the pathogenesis of systemic lupus erythematosus. Curr Opin Immunol (2020) 67:87&#x2013;94. doi: 10.1016/j.coi.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC8054829</ArticleId><ArticleId IdType="pubmed">33246136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. . Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U.S.A. (2010) 107:2159&#x2013;64. doi:&#xa0;10.1073/pnas.0904055107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0904055107</ArticleId><ArticleId IdType="pmc">PMC2836639</ArticleId><ArticleId IdType="pubmed">20080669</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu TC, Huang CY, Liu CH, Hsu KC, Chen YH, Tzang BS. Lactobacillus paracasei GMNL-32, lactobacillus reuteri GMNL-89 and l. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice. Br J Nutr (2017) 117:1066&#x2013;74. doi: 10.1017/S0007114517001039</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114517001039</ArticleId><ArticleId IdType="pubmed">28502277</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BM, Gaudreau MC, Al-Gadban MM, Gudi R, Vasu C. Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin Exp Immunol (2015) 181:323&#x2013;37. doi: 10.1111/cei.12609</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12609</ArticleId><ArticleId IdType="pmc">PMC4516448</ArticleId><ArticleId IdType="pubmed">25703185</ArticleId></ArticleIdList></Reference><Reference><Citation>Doonan J, Tarafdar A, Pineda MA, Lumb FE, Crowe J, Khan AM, et al. . The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis. Nat Commun (2019) 10:1554. doi: 10.1038/s41467-019-09361-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09361-0</ArticleId><ArticleId IdType="pmc">PMC6451002</ArticleId><ArticleId IdType="pubmed">30952846</ArticleId></ArticleIdList></Reference><Reference><Citation>Olia A, Shimokawa C, Imai T, Suzue K, Hisaeda H. Suppression of systemic lupus erythematosus in NZBWF1 mice infected with hymenolepis microstoma. Parasitol Int (2020) 76:102057. doi: 10.1016/j.parint.2020.102057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parint.2020.102057</ArticleId><ArticleId IdType="pubmed">31954872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Zhu Z, Lin X, Li H, Wen C, Bao J, et al. . Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice. Arthritis Res Ther (2021) 23:240. doi: 10.1186/s13075-021-02620-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02620-w</ArticleId><ArticleId IdType="pmc">PMC8439074</ArticleId><ArticleId IdType="pubmed">34521450</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XB, Chu XJ, Cao NW, Wang H, Fang XY, Fan YG, et al. . Proton pump inhibitors induce changes in the gut microbiome composition of systemic lupus erythematosus patients. BMC Microbiol (2022) 22:117. doi: 10.1186/s12866-022-02533-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-022-02533-x</ArticleId><ArticleId IdType="pmc">PMC9043501</ArticleId><ArticleId IdType="pubmed">35477382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Qing P, Yang H, Wu Y, Liu Y, Luo Y. Gut microbiome and metabolites in systemic lupus erythematosus: link, mechanisms and intervention. Front Immunol (2021) 12:686501. doi: 10.3389/fimmu.2021.686501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686501</ArticleId><ArticleId IdType="pmc">PMC8319742</ArticleId><ArticleId IdType="pubmed">34335588</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>